Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harrow Inc
(NQ:
HROW
)
24.48
-0.80 (-3.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
298,957
Open
25.00
Bid (Size)
24.49 (2)
Ask (Size)
24.51 (54)
Prev. Close
25.28
Today's Range
24.22 - 25.44
52wk Range
7.600 - 25.58
Shares Outstanding
35,382
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Harrow to Attend 2024 ASRS Annual Meeting
July 12, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
July 09, 2024
From
Harrow, Inc.
Via
Business Wire
Performance
YTD
+104.85%
+104.85%
1 Month
+13.97%
+13.97%
3 Month
+137.21%
+137.21%
6 Month
+146.53%
+146.53%
1 Year
+15.15%
+15.15%
More News
Read More
Top 3 Health Care Stocks That May Crash This Quarter
July 03, 2024
Via
Benzinga
HROW Stock Earnings: Harrow Beats EPS, Beats Revenue for Q2 2023
July 02, 2024
Via
InvestorPlace
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 20, 2024
Via
Benzinga
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
June 20, 2024
Via
Benzinga
Harrow Provides TRIESENCE® Relaunch Update
June 20, 2024
From
Harrow, Inc.
Via
Business Wire
The Top 7 Growth Stocks to Buy and Hold Until 2030
June 07, 2024
Via
InvestorPlace
Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
June 06, 2024
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
June 05, 2024
From
Harrow, Inc.
Via
Business Wire
3 Stocks Insiders are Buying That Should be on Your Radar
May 28, 2024
Via
MarketBeat
Harrow to Present at Two Investor Conferences in May
May 15, 2024
From
Harrow, Inc.
Via
Business Wire
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 14, 2024
Via
Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 14, 2024
Via
Benzinga
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
Harrow Announces First Quarter 2024 Financial Results
May 13, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
May 13, 2024
From
Harrow, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
May 03, 2024
Via
Benzinga
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
April 25, 2024
From
Harrow, Inc.
Via
Business Wire
Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying
April 25, 2024
Via
Benzinga
Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying
April 22, 2024
Via
Benzinga
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
April 02, 2024
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.